PubMed:16810074
Annnotations
LitCoin-entities-OrganismTaxon-PD
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 634-638 | OrganismTaxon | denotes | Rats | NCBItxid:10118|NCBItxid:10116|NCBItxid:10114 |
| T4 | 765-769 | OrganismTaxon | denotes | rats | NCBItxid:10118|NCBItxid:10116|NCBItxid:10114 |
| T7 | 829-833 | OrganismTaxon | denotes | rats | NCBItxid:10118|NCBItxid:10116|NCBItxid:10114 |
| T10 | 1033-1037 | OrganismTaxon | denotes | rats | NCBItxid:10118|NCBItxid:10116|NCBItxid:10114 |
| T13 | 1403-1412 | OrganismTaxon | denotes | scavenger | NCBItxid:30848 |
| T14 | 1503-1507 | OrganismTaxon | denotes | rats | NCBItxid:10118|NCBItxid:10116|NCBItxid:10114 |
| T17 | 1553-1557 | OrganismTaxon | denotes | rats | NCBItxid:10118|NCBItxid:10116|NCBItxid:10114 |
| T20 | 1712-1716 | OrganismTaxon | denotes | rats | NCBItxid:10118|NCBItxid:10116|NCBItxid:10114 |
| T23 | 1756-1760 | OrganismTaxon | denotes | rats | NCBItxid:10118|NCBItxid:10116|NCBItxid:10114 |
| T26 | 1843-1847 | OrganismTaxon | denotes | rats | NCBItxid:10118|NCBItxid:10116|NCBItxid:10114 |
| T29 | 1919-1923 | OrganismTaxon | denotes | rats | NCBItxid:10118|NCBItxid:10116|NCBItxid:10114 |
LitCoin-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-93 | Sentence | denotes | Mechanisms of hypertension induced by nitric oxide (NO) deficiency: focus on venous function. |
| T2 | 94-199 | Sentence | denotes | Loss of endothelial cell-derived nitric oxide (NO) in hypertension is a hallmark of arterial dysfunction. |
| T3 | 200-340 | Sentence | denotes | Experimental hypertension created by the removal of NO, however, involves mechanisms in addition to decreased arterial vasodilator activity. |
| T4 | 341-478 | Sentence | denotes | These include augmented endothelin-1 (ET-1) release, increased sympathetic nervous system activity, and elevated tissue oxidative stress. |
| T5 | 479-633 | Sentence | denotes | We hypothesized that increased venous smooth muscle (venomotor) tone plays a role in Nomega-nitro-L-arginine (LNNA) hypertension through these mechanisms. |
| T6 | 634-728 | Sentence | denotes | Rats were treated with the NO synthase inhibitor LNNA (0.5 g/L in drinking water) for 2 weeks. |
| T7 | 729-843 | Sentence | denotes | Mean arterial pressure of conscious rats was 119 +/- 2 mm Hg in control and 194 +/- 5 mm Hg in LNNA rats (P<0.05). |
| T8 | 844-929 | Sentence | denotes | Carotid arteries and vena cava were removed for measurement of isometric contraction. |
| T9 | 930-1118 | Sentence | denotes | Maximal contraction to norepinephrine was modestly reduced in arteries from LNNA compared with control rats whereas the maximum contraction to ET-1 was significantly reduced (54% control). |
| T10 | 1119-1248 | Sentence | denotes | Maximum contraction of vena cava to norepinephrine (37% control) also was reduced but no change in response to ET-1 was observed. |
| T11 | 1249-1387 | Sentence | denotes | Mean circulatory filling pressure, an in vivo measure of venomotor tone, was not elevated in LNNA hypertension at 1 or 2 weeks after LNNA. |
| T12 | 1388-1604 | Sentence | denotes | The superoxide scavenger tempol (30, 100, and 300 micromol kg(-1), IV) did not change arterial pressure in control rats but caused a dose-dependent decrease in LNNA rats (-18 +/- 8, -26 +/- 15, and -54 +/- 11 mm Hg). |
| T13 | 1605-1779 | Sentence | denotes | Similarly, ganglionic blockade with hexamethonium caused a significantly greater fall in LNNA hypertensive rats (76 +/- 9 mm Hg) compared with control rats (35 +/- 10 mm Hg). |
| T14 | 1780-1924 | Sentence | denotes | Carotid arteries, vena cava, and sympathetic ganglia from LNNA rats had higher basal levels of superoxide compared with those from control rats. |
| T15 | 1925-2142 | Sentence | denotes | These data suggest that while NO deficiency increases oxidative stress and sympathetic activity in both arterial and venous vessels, the impact on veins does not make a major contribution to this form of hypertension. |
LitCoin-entities
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 3067 | 14-26 | DiseaseOrPhenotypicFeature | denotes | hypertension | MESH:D006973 |
| 3068 | 38-50 | ChemicalEntity | denotes | nitric oxide | MESH:D009569 |
| 3069 | 52-54 | ChemicalEntity | denotes | NO | MESH:D009569 |
| 3070 | 127-139 | ChemicalEntity | denotes | nitric oxide | MESH:D009569 |
| 3071 | 141-143 | ChemicalEntity | denotes | NO | MESH:D009569 |
| 3072 | 148-160 | DiseaseOrPhenotypicFeature | denotes | hypertension | MESH:D006973 |
| 3073 | 178-198 | DiseaseOrPhenotypicFeature | denotes | arterial dysfunction | MESH:D018754 |
| 3074 | 213-225 | DiseaseOrPhenotypicFeature | denotes | hypertension | MESH:D006973 |
| 3075 | 252-254 | ChemicalEntity | denotes | NO | MESH:D009569 |
| 3076 | 365-377 | GeneOrGeneProduct | denotes | endothelin-1 | NCBIGene:24323 |
| 3077 | 379-383 | GeneOrGeneProduct | denotes | ET-1 | NCBIGene:24323 |
| 3078 | 564-587 | ChemicalEntity | denotes | Nomega-nitro-L-arginine | MESH:D019335 |
| 3079 | 589-593 | ChemicalEntity | denotes | LNNA | MESH:D019335 |
| 3080 | 595-607 | DiseaseOrPhenotypicFeature | denotes | hypertension | MESH:D006973 |
| 3081 | 634-638 | OrganismTaxon | denotes | Rats | NCBITaxon:10116 |
| 3082 | 661-672 | GeneOrGeneProduct | denotes | NO synthase | NCBIGene:24598 |
| 3083 | 683-687 | ChemicalEntity | denotes | LNNA | MESH:D019335 |
| 3084 | 765-769 | OrganismTaxon | denotes | rats | NCBITaxon:10116 |
| 3085 | 824-828 | ChemicalEntity | denotes | LNNA | MESH:D019335 |
| 3086 | 829-833 | OrganismTaxon | denotes | rats | NCBITaxon:10116 |
| 3087 | 953-967 | ChemicalEntity | denotes | norepinephrine | MESH:D009638 |
| 3088 | 1006-1010 | ChemicalEntity | denotes | LNNA | MESH:D019335 |
| 3089 | 1033-1037 | OrganismTaxon | denotes | rats | NCBITaxon:10116 |
| 3090 | 1073-1077 | GeneOrGeneProduct | denotes | ET-1 | NCBIGene:24323 |
| 3091 | 1155-1169 | ChemicalEntity | denotes | norepinephrine | MESH:D009638 |
| 3092 | 1230-1234 | GeneOrGeneProduct | denotes | ET-1 | NCBIGene:24323 |
| 3093 | 1342-1346 | ChemicalEntity | denotes | LNNA | MESH:D019335 |
| 3094 | 1347-1359 | DiseaseOrPhenotypicFeature | denotes | hypertension | MESH:D006973 |
| 3095 | 1382-1386 | ChemicalEntity | denotes | LNNA | MESH:D019335 |
| 3096 | 1392-1402 | ChemicalEntity | denotes | superoxide | MESH:D013481 |
| 3097 | 1413-1419 | ChemicalEntity | denotes | tempol | MESH:C001803 |
| 3098 | 1503-1507 | OrganismTaxon | denotes | rats | NCBITaxon:10116 |
| 3099 | 1548-1552 | ChemicalEntity | denotes | LNNA | MESH:D019335 |
| 3100 | 1553-1557 | OrganismTaxon | denotes | rats | NCBITaxon:10116 |
| 3101 | 1641-1654 | ChemicalEntity | denotes | hexamethonium | MESH:D018738 |
| 3102 | 1694-1698 | ChemicalEntity | denotes | LNNA | MESH:D019335 |
| 3103 | 1699-1711 | DiseaseOrPhenotypicFeature | denotes | hypertensive | MESH:D006973 |
| 3104 | 1712-1716 | OrganismTaxon | denotes | rats | NCBITaxon:10116 |
| 3105 | 1756-1760 | OrganismTaxon | denotes | rats | NCBITaxon:10116 |
| 3106 | 1838-1842 | ChemicalEntity | denotes | LNNA | MESH:D019335 |
| 3107 | 1843-1847 | OrganismTaxon | denotes | rats | NCBITaxon:10116 |
| 3108 | 1875-1885 | ChemicalEntity | denotes | superoxide | MESH:D013481 |
| 3109 | 1919-1923 | OrganismTaxon | denotes | rats | NCBITaxon:10116 |
| 3110 | 1955-1957 | ChemicalEntity | denotes | NO | MESH:D009569 |
| 3111 | 2129-2141 | DiseaseOrPhenotypicFeature | denotes | hypertension | MESH:D006973 |
LitCoin_Mondo
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 102-113 | DiseaseOrPhenotypicFeature | denotes | endothelial | 0015292 |
LitCoin-GeneOrGeneProduct-v0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 14-26 | GeneOrGeneProduct | denotes | hypertension |
| T2 | 27-34 | GeneOrGeneProduct | denotes | induced |
| T3 | 102-113 | GeneOrGeneProduct | denotes | endothelial |
| T4 | 114-118 | GeneOrGeneProduct | denotes | cell |
| T5 | 148-160 | GeneOrGeneProduct | denotes | hypertension |
| T6 | 213-225 | GeneOrGeneProduct | denotes | hypertension |
| T7 | 226-233 | GeneOrGeneProduct | denotes | created |
| T8 | 331-339 | GeneOrGeneProduct | denotes | activity |
| T9 | 365-377 | GeneOrGeneProduct | denotes | endothelin-1 |
| T10 | 379-383 | GeneOrGeneProduct | denotes | ET-1 |
| T11 | 416-423 | GeneOrGeneProduct | denotes | nervous |
| T12 | 431-439 | GeneOrGeneProduct | denotes | activity |
| T13 | 517-530 | GeneOrGeneProduct | denotes | smooth muscle |
| T14 | 595-607 | GeneOrGeneProduct | denotes | hypertension |
| T15 | 661-672 | GeneOrGeneProduct | denotes | NO synthase |
| T16 | 673-682 | GeneOrGeneProduct | denotes | inhibitor |
| T17 | 865-869 | GeneOrGeneProduct | denotes | vena |
| T18 | 870-874 | GeneOrGeneProduct | denotes | cava |
| T19 | 981-988 | GeneOrGeneProduct | denotes | reduced |
| T20 | 1073-1077 | GeneOrGeneProduct | denotes | ET-1 |
| T21 | 1096-1103 | GeneOrGeneProduct | denotes | reduced |
| T22 | 1142-1146 | GeneOrGeneProduct | denotes | vena |
| T23 | 1147-1151 | GeneOrGeneProduct | denotes | cava |
| T24 | 1193-1200 | GeneOrGeneProduct | denotes | reduced |
| T25 | 1230-1234 | GeneOrGeneProduct | denotes | ET-1 |
| T26 | 1266-1273 | GeneOrGeneProduct | denotes | filling |
| T27 | 1347-1359 | GeneOrGeneProduct | denotes | hypertension |
| T28 | 1360-1364 | GeneOrGeneProduct | denotes | at 1 |
| T29 | 1365-1369 | GeneOrGeneProduct | denotes | or 2 |
| T30 | 1571-1580 | GeneOrGeneProduct | denotes | 26 +/- 15 |
| T31 | 1605-1614 | GeneOrGeneProduct | denotes | Similarly |
| T32 | 1699-1711 | GeneOrGeneProduct | denotes | hypertensive |
| T33 | 1798-1802 | GeneOrGeneProduct | denotes | vena |
| T34 | 1803-1807 | GeneOrGeneProduct | denotes | cava |
| T35 | 2012-2020 | GeneOrGeneProduct | denotes | activity |
| T36 | 2062-2068 | GeneOrGeneProduct | denotes | impact |
| T37 | 2072-2077 | GeneOrGeneProduct | denotes | veins |
| T38 | 2094-2099 | GeneOrGeneProduct | denotes | major |
| T39 | 2129-2141 | GeneOrGeneProduct | denotes | hypertension |
LitCoin-GeneOrGeneProduct-v2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 14-26 | GeneOrGeneProduct | denotes | hypertension |
| T2 | 102-113 | GeneOrGeneProduct | denotes | endothelial |
| T3 | 114-118 | GeneOrGeneProduct | denotes | cell |
| T4 | 148-160 | GeneOrGeneProduct | denotes | hypertension |
| T5 | 213-225 | GeneOrGeneProduct | denotes | hypertension |
| T6 | 365-377 | GeneOrGeneProduct | denotes | endothelin-1 |
| T7 | 379-383 | GeneOrGeneProduct | denotes | ET-1 |
| T8 | 416-423 | GeneOrGeneProduct | denotes | nervous |
| T9 | 517-530 | GeneOrGeneProduct | denotes | smooth muscle |
| T10 | 595-607 | GeneOrGeneProduct | denotes | hypertension |
| T11 | 661-672 | GeneOrGeneProduct | denotes | NO synthase |
| T12 | 673-682 | GeneOrGeneProduct | denotes | inhibitor |
| T13 | 981-988 | GeneOrGeneProduct | denotes | reduced |
| T14 | 1073-1077 | GeneOrGeneProduct | denotes | ET-1 |
| T15 | 1096-1103 | GeneOrGeneProduct | denotes | reduced |
| T16 | 1193-1200 | GeneOrGeneProduct | denotes | reduced |
| T17 | 1230-1234 | GeneOrGeneProduct | denotes | ET-1 |
| T18 | 1347-1359 | GeneOrGeneProduct | denotes | hypertension |
| T19 | 1571-1580 | GeneOrGeneProduct | denotes | 26 +/- 15 |
| T20 | 2062-2068 | GeneOrGeneProduct | denotes | impact |
| T21 | 2094-2099 | GeneOrGeneProduct | denotes | major |
| T22 | 2129-2141 | GeneOrGeneProduct | denotes | hypertension |
LitCoin-Disease-MeSH
| Id | Subject | Object | Predicate | Lexical cue | originalLabel |
|---|---|---|---|---|---|
| T1 | 14-26 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 |
| T2 | 148-160 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 |
| T3 | 213-225 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 |
| T4 | 595-607 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 |
| T5 | 1347-1359 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 |
| T6 | 1616-1626 | DiseaseOrPhenotypicFeature | denotes | ganglionic | D045888 |
| T7 | 1699-1711 | DiseaseOrPhenotypicFeature | denotes | hypertensive | D006973 |
| T8 | 2129-2141 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 |
LitCoin-GeneOrGeneProduct-v3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 365-377 | GeneOrGeneProduct | denotes | endothelin-1 |
| T2 | 379-383 | GeneOrGeneProduct | denotes | ET-1 |
| T3 | 517-530 | GeneOrGeneProduct | denotes | smooth muscle |
| T4 | 661-672 | GeneOrGeneProduct | denotes | NO synthase |
| T5 | 1073-1077 | GeneOrGeneProduct | denotes | ET-1 |
| T6 | 1230-1234 | GeneOrGeneProduct | denotes | ET-1 |
| T7 | 1571-1580 | GeneOrGeneProduct | denotes | 26 +/- 15 |
LitCoin_Mondo_095
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 14-26 | DiseaseOrPhenotypicFeature | denotes | hypertension | 0005044 |
| T2 | 148-160 | DiseaseOrPhenotypicFeature | denotes | hypertension | 0005044 |
| T3 | 213-225 | DiseaseOrPhenotypicFeature | denotes | hypertension | 0005044 |
| T4 | 379-381 | DiseaseOrPhenotypicFeature | denotes | ET | 0005029 |
| T5 | 595-607 | DiseaseOrPhenotypicFeature | denotes | hypertension | 0005044 |
| T6 | 1073-1075 | DiseaseOrPhenotypicFeature | denotes | ET | 0005029 |
| T7 | 1230-1232 | DiseaseOrPhenotypicFeature | denotes | ET | 0005029 |
| T8 | 1347-1359 | DiseaseOrPhenotypicFeature | denotes | hypertension | 0005044 |
| T9 | 2129-2141 | DiseaseOrPhenotypicFeature | denotes | hypertension | 0005044 |
LitCoin-MeSH-Disease-2
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T1 | 14-26 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 |
| T2 | 148-160 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 |
| T3 | 178-198 | DiseaseOrPhenotypicFeature | denotes | arterial dysfunction | DISEASE |
| T4 | 213-225 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 |
| T5 | 595-607 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 |
| T6 | 1347-1359 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 |
| T7 | 2129-2141 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 |
LitCoin-MONDO_bioort2019
| Id | Subject | Object | Predicate | Lexical cue | #label |
|---|---|---|---|---|---|
| T1 | 14-26 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 |
| T2 | 148-160 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 |
| T3 | 178-198 | DiseaseOrPhenotypicFeature | denotes | arterial dysfunction | DISEASE |
| T4 | 213-225 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 |
| T5 | 595-607 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 |
| T6 | 1347-1359 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 |
| T7 | 2129-2141 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 |
LitCoin-Chemical-MeSH-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T1 | 38-50 | ChemicalEntity | denotes | nitric oxide | D009569|http://purl.obolibrary.org/obo/CHEBI_16480 |
| T3 | 127-139 | ChemicalEntity | denotes | nitric oxide | D009569|http://purl.obolibrary.org/obo/CHEBI_16480 |
| T5 | 365-377 | ChemicalEntity | denotes | endothelin-1 | http://purl.obolibrary.org/obo/CHEBI_80240 |
| T6 | 571-576 | ChemicalEntity | denotes | nitro | http://purl.obolibrary.org/obo/CHEBI_29785 |
| T7 | 577-587 | ChemicalEntity | denotes | L-arginine | http://purl.obolibrary.org/obo/CHEBI_32682|http://purl.obolibrary.org/obo/CHEBI_29952|http://purl.obolibrary.org/obo/CHEBI_16467 |
| T10 | 589-593 | ChemicalEntity | denotes | LNNA | http://purl.obolibrary.org/obo/CHEBI_32682 |
| T11 | 661-672 | ChemicalEntity | denotes | NO synthase | D019001 |
| T12 | 683-687 | ChemicalEntity | denotes | LNNA | http://purl.obolibrary.org/obo/CHEBI_32682 |
| T13 | 700-714 | ChemicalEntity | denotes | drinking water | D060766 |
| T14 | 824-828 | ChemicalEntity | denotes | LNNA | http://purl.obolibrary.org/obo/CHEBI_32682 |
| T15 | 953-967 | ChemicalEntity | denotes | norepinephrine | D009638|http://purl.obolibrary.org/obo/CHEBI_33569|http://purl.obolibrary.org/obo/CHEBI_18357 |
| T18 | 1006-1010 | ChemicalEntity | denotes | LNNA | http://purl.obolibrary.org/obo/CHEBI_32682 |
| T19 | 1155-1169 | ChemicalEntity | denotes | norepinephrine | D009638|http://purl.obolibrary.org/obo/CHEBI_33569|http://purl.obolibrary.org/obo/CHEBI_18357 |
| T22 | 1342-1346 | ChemicalEntity | denotes | LNNA | http://purl.obolibrary.org/obo/CHEBI_32682 |
| T23 | 1382-1386 | ChemicalEntity | denotes | LNNA | http://purl.obolibrary.org/obo/CHEBI_32682 |
| T24 | 1392-1402 | ChemicalEntity | denotes | superoxide | D013481|http://purl.obolibrary.org/obo/CHEBI_18421 |
| T26 | 1413-1419 | ChemicalEntity | denotes | tempol | C001803|ChemicalEntity |
| T28 | 1548-1552 | ChemicalEntity | denotes | LNNA | http://purl.obolibrary.org/obo/CHEBI_32682 |
| T29 | 1641-1654 | ChemicalEntity | denotes | hexamethonium | D018738 |
| T30 | 1694-1698 | ChemicalEntity | denotes | LNNA | http://purl.obolibrary.org/obo/CHEBI_32682 |
| T31 | 1838-1842 | ChemicalEntity | denotes | LNNA | http://purl.obolibrary.org/obo/CHEBI_32682 |
| T32 | 1875-1885 | ChemicalEntity | denotes | superoxide | D013481|http://purl.obolibrary.org/obo/CHEBI_18421 |
LitCoin-NCBITaxon-2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-10 | OrganismTaxon | denotes | Mechanisms |
| T2 | 634-638 | OrganismTaxon | denotes | Rats |
| T3 | 765-769 | OrganismTaxon | denotes | rats |
| T4 | 829-833 | OrganismTaxon | denotes | rats |
| T5 | 1033-1037 | OrganismTaxon | denotes | rats |
| T6 | 1403-1412 | OrganismTaxon | denotes | scavenger |
| T7 | 1503-1507 | OrganismTaxon | denotes | rats |
| T8 | 1553-1557 | OrganismTaxon | denotes | rats |
| T9 | 1712-1716 | OrganismTaxon | denotes | rats |
| T10 | 1756-1760 | OrganismTaxon | denotes | rats |
| T11 | 1843-1847 | OrganismTaxon | denotes | rats |
| T12 | 1919-1923 | OrganismTaxon | denotes | rats |
LitCoin-training-merged
| Id | Subject | Object | Predicate | Lexical cue | #label | ID: |
|---|---|---|---|---|---|---|
| T32 | 1875-1885 | ChemicalEntity | denotes | superoxide | http://purl.obolibrary.org/obo/CHEBI_18421|D013481 | |
| T31 | 1838-1842 | ChemicalEntity | denotes | LNNA | http://purl.obolibrary.org/obo/CHEBI_32682 | |
| T30 | 1694-1698 | ChemicalEntity | denotes | LNNA | http://purl.obolibrary.org/obo/CHEBI_32682 | |
| T29 | 1641-1654 | ChemicalEntity | denotes | hexamethonium | D018738 | |
| T28 | 1548-1552 | ChemicalEntity | denotes | LNNA | http://purl.obolibrary.org/obo/CHEBI_32682 | |
| T26 | 1413-1419 | ChemicalEntity | denotes | tempol | ChemicalEntity|C001803 | |
| T24 | 1392-1402 | ChemicalEntity | denotes | superoxide | http://purl.obolibrary.org/obo/CHEBI_18421|D013481 | |
| T23 | 1382-1386 | ChemicalEntity | denotes | LNNA | http://purl.obolibrary.org/obo/CHEBI_32682 | |
| T22 | 1342-1346 | ChemicalEntity | denotes | LNNA | http://purl.obolibrary.org/obo/CHEBI_32682 | |
| T19 | 1155-1169 | ChemicalEntity | denotes | norepinephrine | http://purl.obolibrary.org/obo/CHEBI_18357|http://purl.obolibrary.org/obo/CHEBI_33569|D009638 | |
| T18 | 1006-1010 | ChemicalEntity | denotes | LNNA | http://purl.obolibrary.org/obo/CHEBI_32682 | |
| T15 | 953-967 | ChemicalEntity | denotes | norepinephrine | http://purl.obolibrary.org/obo/CHEBI_18357|http://purl.obolibrary.org/obo/CHEBI_33569|D009638 | |
| T14 | 824-828 | ChemicalEntity | denotes | LNNA | http://purl.obolibrary.org/obo/CHEBI_32682 | |
| T13 | 700-714 | ChemicalEntity | denotes | drinking water | D060766 | |
| T12 | 683-687 | ChemicalEntity | denotes | LNNA | http://purl.obolibrary.org/obo/CHEBI_32682 | |
| T11 | 661-672 | ChemicalEntity | denotes | NO synthase | D019001 | |
| T10 | 589-593 | ChemicalEntity | denotes | LNNA | http://purl.obolibrary.org/obo/CHEBI_32682 | |
| T7 | 577-587 | ChemicalEntity | denotes | L-arginine | http://purl.obolibrary.org/obo/CHEBI_16467|http://purl.obolibrary.org/obo/CHEBI_29952|http://purl.obolibrary.org/obo/CHEBI_32682 | |
| T6 | 571-576 | ChemicalEntity | denotes | nitro | http://purl.obolibrary.org/obo/CHEBI_29785 | |
| T5 | 365-377 | ChemicalEntity | denotes | endothelin-1 | http://purl.obolibrary.org/obo/CHEBI_80240 | |
| T3 | 127-139 | ChemicalEntity | denotes | nitric oxide | http://purl.obolibrary.org/obo/CHEBI_16480|D009569 | |
| T1 | 38-50 | ChemicalEntity | denotes | nitric oxide | http://purl.obolibrary.org/obo/CHEBI_16480|D009569 | |
| T8889 | 1571-1580 | GeneOrGeneProduct | denotes | 26 +/- 15 | ||
| T31362 | 1230-1234 | GeneOrGeneProduct | denotes | ET-1 | ||
| T41184 | 1073-1077 | GeneOrGeneProduct | denotes | ET-1 | ||
| T4 | 661-672 | GeneOrGeneProduct | denotes | NO synthase | ||
| T99910 | 517-530 | GeneOrGeneProduct | denotes | smooth muscle | ||
| T2 | 379-383 | GeneOrGeneProduct | denotes | ET-1 | ||
| T1842 | 365-377 | GeneOrGeneProduct | denotes | endothelin-1 | ||
| T7291 | 2129-2141 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 | |
| T43459 | 1347-1359 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 | |
| T32546 | 595-607 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 | |
| T15697 | 213-225 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 | |
| T79970 | 178-198 | DiseaseOrPhenotypicFeature | denotes | arterial dysfunction | DISEASE | |
| T44855 | 148-160 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 | |
| T33848 | 14-26 | DiseaseOrPhenotypicFeature | denotes | hypertension | D006973 | |
| T58971 | 1919-1923 | OrganismTaxon | denotes | rats | ||
| T33574 | 1843-1847 | OrganismTaxon | denotes | rats | ||
| T57872 | 1756-1760 | OrganismTaxon | denotes | rats | ||
| T9 | 1712-1716 | OrganismTaxon | denotes | rats | ||
| T8 | 1553-1557 | OrganismTaxon | denotes | rats | ||
| T73726 | 1503-1507 | OrganismTaxon | denotes | rats | ||
| T32699 | 1403-1412 | OrganismTaxon | denotes | scavenger | ||
| T89176 | 1033-1037 | OrganismTaxon | denotes | rats | ||
| T11049 | 829-833 | OrganismTaxon | denotes | rats | ||
| T10011 | 765-769 | OrganismTaxon | denotes | rats | ||
| T67116 | 634-638 | OrganismTaxon | denotes | Rats | ||
| T77778 | 0-10 | OrganismTaxon | denotes | Mechanisms |